Constellation
FDA-cleared image-analysis software for whole-body MRI segmentation and quantification
Software · EmbeddedCompany source
Company profile
About Q Bio
Q Bio is a health technology company that has rebuilt the physical exam for the era of longitudinal health. Founded in 2015 and headquartered in Redwood City, California, Q Bio integrates advanced medical technology to make preventive health more comprehensive, scalable, and actionable. The company delivers the Q Exam—a comprehensive physical examination that captures whole-body MRI imaging, 120+ blood biomarkers, genetic analysis of 163 risk-relevant genes, wearable device data, and medical history in a single visit. Each exam is reviewed by a board-certified Q Bio physician in a 45-minute consultation. The company's FDA-cleared image-analysis software, Constellation, segments organs and tissues from MRI scans, quantifying key measurements for radiologist and physician review. All results are organized in the Q Bio Health Dashboard, a longitudinal clinical record that makes every future exam comparable to the member's own baseline. Rather than providing episodic snapshots like traditional annual physicals, the Q Exam establishes a comprehensive baseline that is compared year-over-year against the patient's own prior measurements. Q Bio delivers the exam directly at its Redwood City clinic and through enterprise partnerships with concierge medicine practices, executive health programs, longevity clinics, health systems, and employer programs. The platform is designed to integrate into partners' existing care models and brand experiences, with Q Bio providing the protocol, data infrastructure, and Dashboard while partners maintain the patient relationship and clinical environment.
Company description Q Bio official website
Primary marketPrecision Medicine & Genomics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Q Bio?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
- Concierge medicine practices
- Direct-to-consumer (Redwood City clinic)
- Employer/member programs
- Executive health programs
- Family office care relationships
- Health systems
- High-net-worth preventive care
- Longevity clinics
Deployment & integration
Cloud Saas · Embedded · Hybrid deployment with recorded integration context.
Geographic context
MarketsCanada · International deployments evaluated on partner-by-partner basis · United States
Company sourceOfficial website
Company milestones
Platform expansion
Q Bio Clinic opened in Redwood City in 2020; Dashboard matured into longitudinal clinical product 2021-2023; Platform development and refinement from 2016-2019
Partnerships
Recorded partners
- Leading North American health organization (unnamed enterprise partner mentioned in case example)
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
Q Bio Health Dashboard
Longitudinal clinical record that makes every future exam comparable to baseline measurements
Platform · Cloud SaaSCompany source
Q Exam
Comprehensive longitudinal physical exam combining whole-body MRI, biomarkers, genetics, and physician review
Service · HybridCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Ultra-high gradient connectomics and microstructure MRI scanner for imaging of human brain circuits across scales.Nature biomedical engineering · Feb 1, 2026
Publisher Correction: Ultra-high gradient connectomics and microstructure MRI scanner for imaging of human brain circuits across scales.Nature biomedical engineering · Feb 1, 2026
Eddy current-induced artifact correction in high b-value ex vivo human brain diffusion MRI with dynamic field monitoring.Magnetic resonance in medicine · Feb 1, 2024
Acoustic radiation force impulse predicts long-term outcomes in a large-scale cohort: High liver cancer, low comorbidity in hepatitis B virus.World journal of gastroenterology · Apr 14, 2023
Linear multi-scale modeling of diffusion MRI data: A framework for characterization of oriented structures across length scales.Human brain mapping · Mar 1, 2023
High-fidelity, high-spatial-resolution diffusion magnetic resonance imaging of ex vivo whole human brain at ultra-high gradient strength with structured low-rank echo-planar imaging ghost correction.NMR in biomedicine · Feb 1, 2023
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
Constellation (CON-001)K241280 · 510k · Sep 12, 2024
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Clinical findings identification
Routinely identifies findings worth follow-up conversation at first exam, with meaningful share changing member's preventive plan
Leading North American health provider
Enterprise deployment of Q Exam as part of preventive care program for members
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
Garry Choy
Co-founder
06 · Company updates
Updates from Q Bio
Recent articles published on Q Bio's official website.
No Company updates are currently listed.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Precision Medicine & Genomics
Companies using AI to analyze genomic, proteomic, metabolomic, or multi-omics data to provide personalized treatment recommendations, identify genetic risks, or develop targeted therapies. Includes genomic sequencing platforms with AI analysis, preventive medicine based on genetic risk assessment, and longevity care based on molecular and genetic data.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.